Cross-sectional analysis explores the association between epicardial fat and glycated albumin in neonates, indicating potential early predictors of cardiometabolic risk.
Key Points
Elevated epicardial fat thickness and glycated albumin levels suggest increased cardiometabolic risk in infants of diabetic mothers.
A cutoff of >16.3 mm for epicardial fat showed 93.1% specificity and 54.29% sensitivity in identifying at-risk neonates.
Echocardiography and ELISA were utilized to measure epicardial fat thickness and glycated albumin from umbilical cord blood.
Incorporating these biomarkers into assessments can enhance early diagnosis and targeted interventions for at-risk neonates.